TREM2 variants as a possible cause of frontotemporal dementia with distinct neuroimaging features
Abstract
Background and purpose: Nasu–Hakola disease (NHD) is a rare, autosomal recessive disorder characterized by skeletal and neurological symptoms. Behavioral symptoms with cognitive impairment may mimic the behavioral variant of frontotemporal dementia (bvFTD) and other early‐onset dementias. Our patients were analyzed and the literature was reviewed to delineate neurological and neuroimaging findings suggestive of NHD. Method: Fourteen patients carrying a pathogenic mutation in the TREM2 gene were found in our database. Demographic, clinical, laboratory and radiological data were retrieved and analyzed. Results: The presenting clinical picture was behavioral changes with cognitive decline resembling bvFTD in all patients. The mean age was 37.1 ± 4.97 years and the mean duration of the disease was 8.9 ± 3.51 years. Only two patients had typical bone cysts. Seven patients had bilateral calcification of the basal ganglia in computed tomography of the brain. Magnetic resonance imaging of the brain revealed severe atrophy of the corpus callosum, enlargement of the ventricles, atrophy of the caudate nuclei and periventricular white matter changes in all patients. Symmetrical global atrophy of the brain mainly affecting frontoparietal and lateral temporal regions were observed in all cases, and 13 patients had atrophy of the hippocampus. Cerebrospinal fluid examination of 10 patients showed elevated protein levels in six and the presence of oligoclonal bands in four patients. Conclusion: A combination of white matter changes, enlarged ventricles, atrophy of the caudate nuclei and thinning of the corpus callosum in magnetic resonance imaging strongly suggests NHD in patients with FTD syndrome. Molecular genetic analysis should be performed in suspected cases, and families should receive genetic counseling.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Homozygous TREM2 mutations are associated with Nasu-Hakola disease or frontotemporal dementia, while TREM2 variants associated with AD are heterozygous.
“Homozygous mutations are associated with Nasu–Hakola disease (NHD),189 or frontotemporal dementia,190 while the TREM2 variants associates with AD are heterozygous.191”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [190]
Cites
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.30 · Cited by 32,594 · see citing works
Rayaprolu, S., Mullen, B., Baker, M., Lynch, T., Finger, E., Seeley, W. W., Hatanpaa, K. J., Lomen-Hoerth, C., Kertesz, A., Bigio, E. H., et al. (2013) · Molecular Neurodegeneration · doi:10.1186/1750-1326-8-19 · Cited by 404 · see citing works
Guerreiro, R. J., Lohmann, E., Brás, J. M., Gibbs, J. R., Rohrer, J. D., Gurunlian, N., Dursun, B., Bilgic, B., Hanagasi, H., Gurvit, H., et al. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.579 · Cited by 374 · cited 2× · see citing works
“A limited number of case reports described neuroimaging findings in NHD patients presenting with neurological symptoms [5,9,32,33] three findings mentioned above were present in all these cases.”
BackgroundSelf-citationMoore, K. M., Nicholas, J., Grossman, M., McMillan, C. T., Irwin, D. J., Massimo, L., Van Deerlin, V. M., Warren, J. D., Fox, N. C., Rossor, M. N., et al. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30394-1 · Cited by 313 · see citing works
Self-citationTREM2 regulates microglial cell activation in response to demyelination in vivo
Cantoni, C., Bollman, B., Licastro, D., Xie, M., Mikesell, R., Schmidt, R., Yuede, C. M., Galimberti, D., Olivecrona, G., Klein, R. S., et al. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1388-1 · Cited by 296 · see citing works
TREM2-Ligand Interactions in Health and Disease
Kober, D. L., & Brett, T. J. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2017.04.004 · Cited by 284 · cited 1× · see citing works
“TREM2 signaling remains poorly understood and receptor– ligand interactions are complex as there are a variety of ligands of TREM2 receptor such as lipoproteins (low- density lipoprotein) and apolipoproteins (APOE), and bacterial anionic molecules [37,38].”
BackgroundGuerreiro, R., Bilgic, B., Guven, G., Brás, J., Rohrer, J., Lohmann, E., Hanagasi, H., Gurvit, H., & Emre, M. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.06.005 · Cited by 158 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Role of neuroinflammation in neurodegeneration development
Zhang, W., Xiao, D., Mao, Q., & Xia, H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01486-5 · Cited by 1,668 · see citing works
- Authors
- Samanci, B., Bilgiç, B., Gelişin, Ö., Tepgeç, F., Guven, G., Tüfekçioğlu, Z., Alaylıoğlu, M., Hanagasi, H. A., Gürvit, H., Guerreiro, R., Hardy, J., & Emre, M.
- Affiliations
- Behavioral Neurology and Movement Disorders Unit Department of Neurology Istanbul Faculty of Medicine Istanbul University Istanbul Turkey
- Istanbul University (TR)
- Department of Genetics Aziz Sancar Institute of Experimental Medicine Istanbul University Istanbul Turkey
- Istanbul University-Cerrahpaşa (TR)
- Van Andel Institute (US)
- UCL Queen Square Institute of Neurology (GB)
- ORCID
- Venue
- European Journal of Neurology
- Publisher
- Wiley
- Published
- 2021-06
- Volume
- 28
- Issue
- 8
- Pages
- 2603-2613
- ISSN
- 1351-5101 (ISSN-L)
- 1468-1331
- OpenAlex
- W3161092717
- Cited by
- 14
- References
- 7
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 3 · 2023: 4 · 2022: 1
- FWCI
- 1.44
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Neurology (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Parkinson's UK (G-0907, G-1307)
- Rosetrees Trust
- Medical Research Council (MR/K01417X/1, MR/L501542/1, MR/J004758/1)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- TREM2, Nasu-Hakola disease, frontotemporal dementia, behavioral variant frontotemporal dementia, basal ganglia calcification, corpus callosum atrophy, hippocampal atrophy, white matter changes, cerebrospinal fluid oligoclonal bands, bone cysts, neuroimaging features, genetic counseling
- MeSH terms
- Adult, Brain, Humans, Lipodystrophy, Magnetic Resonance Imaging, Membrane Glycoproteins, Osteochondrodysplasias, Receptors, Immunologic, Subacute Sclerosing Panencephalitis, Frontotemporal Dementia, Neuroimaging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review